India  

Covaxin's US approval delayed as FDA asks for more data

IndiaTimes Friday, 11 June 2021
Ocugen Inc said on Thursday it would no longer pursue an emergency use authorization for its Covid-19 vaccine candidate, Covaxin, and would instead aim to file for a full US approval of the shot. Ocugen said the decision was based on a recommendation from the US Food and Drug Administration (FDA), which also requested more information and data for full approval.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

England to scrap quarantine for fully jabbed EU and US visitors [Video]

England to scrap quarantine for fully jabbed EU and US visitors

Fully vaccinated travellers from the US and much of Europe will be able to enter England and Scotland without quarantining, starting next week.Transport Secretary Grant Shapps announced that people who have received both doses of a vaccine approved by the FDA in the US or the European Medicines Agency, which regulates drugs for the European Union and several other countries, will be able to take pre and post-arrival coronavirus tests instead of self-isolating for 10 days after entering England.The rule change comes into effect at 3am on Monday August 2.

Credit: PA - Press Association STUDIO    Duration: 01:03Published
CDC weighs 3rd vaccine dose for immune compromised people as COVID-19 surges in the unvaccinated [Video]

CDC weighs 3rd vaccine dose for immune compromised people as COVID-19 surges in the unvaccinated

The CDC is now discussing a possible third dose for folks with compromised immune systems. During a presentation Thursday, the CDC said the FDA hasn’t received enough data to support a third dose but is continuing to assess safety studies and expert opinion to determine if it's needed.

Credit: ABC Action News    Duration: 02:38Published
Twitter suspends U.S. Republican Greene for posts [Video]

Twitter suspends U.S. Republican Greene for posts

Twitter Inc on Monday said it temporarily suspended Republican U.S. Representative Marjorie Taylor Greene's account for tweets which violated the social media's misinformation policy on COVID-19. Bryan Wood reports.

Credit: Reuters - Politics    Duration: 01:02Published
Gottlieb warns most unvaccinated will get COVID [Video]

Gottlieb warns most unvaccinated will get COVID

[NFA] U.S. COVID-19 infections are climbing in parts of the country with low vaccination rates, and former FDA Commissioner Scott Gottlieb warned a new Delta variant would likely infect most unvaccinated Americans. This report produced by Zachary Goelman.

Credit: Reuters - Politics    Duration: 02:03Published
Experts break down signs of rare side effect reported after J&J vaccine [Video]

Experts break down signs of rare side effect reported after J&J vaccine

Both the CDC and FDA are closely monitoring reports of Guillain-Barré syndrome (GBS) after getting the Johnson & Johnson COVID-19 vaccine. While cases appear rare, Tampa Bay area health experts explain what to look for and share why getting vaccinated is still important.

Credit: ABC Action News    Duration: 02:01Published

Covaxin Covaxin Vaccine against COVID-19

CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield

An expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a..
IndiaTimes

Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin doses

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
IndiaTimes

After suspending Covaxin clinical trials, Brazil closes EUA request

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
IndiaTimes

COVID-19 vaccine for children likely by September: AIIMS Chief

In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
DNA

You Might Like


Related videos from verified sources

FDA Grants Priority Review to Pfizer's COVID-19 Vaccine [Video]

FDA Grants Priority Review to Pfizer's COVID-19 Vaccine

FDA Grants , Priority Review to, Pfizer's COVID-19 Vaccine. On July 16, the U.S. Food and Drug Administration (FDA) announced that the Pfizer/BioNTech COVID-19 vaccine has been granted priority review..

Credit: Wibbitz Top Stories     Duration: 00:52Published
Covaxin approval: WHO chief scientist says Phase-3 data looks promising| Covid-19| Oneindia News [Video]

Covaxin approval: WHO chief scientist says Phase-3 data looks promising| Covid-19| Oneindia News

WHO Chief Scientist Soumya Swaminathan has said Covaxin's Phase-3 data looks promising and the vaccine can hopefully be approved by the WHO by mid to late August. Senior Advocate Harish Salve on Friday..

Credit: Oneindia     Duration: 02:46Published
Moderna Applies for Full COVID-19 Vaccine Authorization [Video]

Moderna Applies for Full COVID-19 Vaccine Authorization

Moderna Applies for Full COVID-19 Vaccine Authorization. On June 1, Moderna followed Pfizer in becoming the second pharmaceutical company to apply to the FDA for full vaccine approval for adults 18..

Credit: Wibbitz Top Stories     Duration: 01:07Published

Related news from verified sources

Serum Institute India set for Novavax COVID vaccine trials on children from July: Report

The Pune-based vaccine makers hope to start the clinical trials of Novavax's Covid-19 vaccine 'Covovax' on children in July making it the fourth anti-COVID-19...
Zee News Also reported by •IndiaTimes

'Centre has given over 27 crores Covid vaccine doses to states, UTs'

The Centre has provided more than 27 crores Covid vaccine doses to the states and Union Territories so far, the ministry of health and family welfare (MoHFW)...
IndiaTimes Also reported by •Zee News

India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon

India on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed...
IndiaTimes